Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Coffee linked to major heart risk | Ablations in ASCs | Catheters recalled | A closer look at PFA | GLP-1 drugs & AFib
Wednesday, June 10, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Heart Rhythm

Is coffee bad for the heart? New research links it to a major risk—and multiple benefits

Drinking a lot of coffee may increase a person's heart attack risk, according to a new meta-analysis. On the other hand, coffee intake was linked to key benefits in the same study.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Is coffee bad for the heart? New research links it to a major risk—and multiple benefits

Share on Twitter Share on Facebook Share on Linkedin
Drinking a lot of coffee may increase a person's heart attack risk, according to a new meta-analysis. On the other hand, coffee intake was linked to key benefits in the same study.
READ MORE >

Key points to remember when performing cardiac ablations in ASCs

When CMS finalized coverage for cardiac ablations performed in ASCs, experts from HRS and ACC published recommendations for performing those procedures safely and effectively. One of the cardiologists behind that guidance shared some important takeaways with Cardiovascular Business. 

READ MORE >
Video: Samuel Jones, MD, MPH, FACC, director of Inpatient Electrophysiology at the Memorial Hospital for Chattanooga Heart Institute, and co-chair of the American College of Cardiology (ACC) and Heart Rhythm Society (HRS) guidance For electrophysiology ablation in ambulatory surgical centers (ASCs), explains the details of this shift in cardiology care delivery.
Share on Twitter Share on Facebook Share on Linkedin

Key points to remember when performing cardiac ablations in ASCs

Share on Twitter Share on Facebook Share on Linkedin
Video: Samuel Jones, MD, MPH, FACC, director of Inpatient Electrophysiology at the Memorial Hospital for Chattanooga Heart Institute, and co-chair of the American College of Cardiology (ACC) and Heart Rhythm Society (HRS) guidance For electrophysiology ablation in ambulatory surgical centers (ASCs), explains the details of this shift in cardiology care delivery.
When CMS finalized coverage for cardiac ablations performed in ASCs, experts from HRS and ACC published recommendations for performing those procedures safely and effectively. One of the cardiologists behind that guidance shared some important takeaways with Cardiovascular Business. 
READ MORE >

Exploring the latest data in PFA and leadless conduction system pacing

Vivek Reddy, MD, spoke to Cardiovascular Business about some of the biggest trends in electrophysiology today.

READ MORE >
Video: Vivek Reddy, MD, Director, Cardiac Arrhythmia Service, The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology, Icahn School of Medicine at Mount Sinai, explains studies on the latest pulsed field ablation and leadless conduction pacing trials. #PFA #conductionpacing
Share on Twitter Share on Facebook Share on Linkedin

Exploring the latest data in PFA and leadless conduction system pacing

Share on Twitter Share on Facebook Share on Linkedin
Video: Vivek Reddy, MD, Director, Cardiac Arrhythmia Service, The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology, Icahn School of Medicine at Mount Sinai, explains studies on the latest pulsed field ablation and leadless conduction pacing trials. #PFA #conductionpacing
Vivek Reddy, MD, spoke to Cardiovascular Business about some of the biggest trends in electrophysiology today.
READ MORE >

Thousands of reprocessed EP catheters recalled

Stryker Sustainability Solutions is recalling more than 8,000 reprocessed medical devices. This is a Class II recall, according to the FDA, and these devices should no longer be used to treat patients.

READ MORE >
Physician warning
Share on Twitter Share on Facebook Share on Linkedin

Thousands of reprocessed EP catheters recalled

Share on Twitter Share on Facebook Share on Linkedin
Physician warning
Stryker Sustainability Solutions is recalling more than 8,000 reprocessed medical devices. This is a Class II recall, according to the FDA, and these devices should no longer be used to treat patients.
READ MORE >

PFA has been a game-changer for heart patients—but there are still risks

Devi Nair, MD, reviewed some of the rare complications clinicians are seeing with PFA.

READ MORE >
Devi Nair, MD, director of electrophysiology and research, St. Bernards Medical Center and Arrhythmia Research Group, spoke with Cardiovascular Business at the Heart Rhythm 2026 meeting in the above video interview. She explained both the explosion of PFA use since the first FDA approvals in 2024, and the recently discovered complications of coronary vessel spasm and hemolysis and how newer PFA technology might address this.
Share on Twitter Share on Facebook Share on Linkedin

PFA has been a game-changer for heart patients—but there are still risks

Share on Twitter Share on Facebook Share on Linkedin
Devi Nair, MD, director of electrophysiology and research, St. Bernards Medical Center and Arrhythmia Research Group, spoke with Cardiovascular Business at the Heart Rhythm 2026 meeting in the above video interview. She explained both the explosion of PFA use since the first FDA approvals in 2024, and the recently discovered complications of coronary vessel spasm and hemolysis and how newer PFA technology might address this.
Devi Nair, MD, reviewed some of the rare complications clinicians are seeing with PFA.
READ MORE >

New-look pacemaker uses ultrasound to stimulate the heart—no implant required

The engineers behind this new device envision a future where patients wear a single postage stamp-sized sticker that images and stimulates the heart. 

READ MORE >
ultrasound pacemaker
Share on Twitter Share on Facebook Share on Linkedin

New-look pacemaker uses ultrasound to stimulate the heart—no implant required

Share on Twitter Share on Facebook Share on Linkedin
ultrasound pacemaker
The engineers behind this new device envision a future where patients wear a single postage stamp-sized sticker that images and stimulates the heart. 
READ MORE >

First US patient implanted with Biotronik leadless pacemaker

The LivIQ leadless pacemaker offers a single-device solution designed to deliver AV synchrony through far-field sensing. 

READ MORE >
 Biotronik's LivIQ leadless pacemaker offers a single-device solution designed to deliver atrioventricular (AV) synchrony through advanced electrical atrial far-field sensing.
Share on Twitter Share on Facebook Share on Linkedin

First US patient implanted with Biotronik leadless pacemaker

Share on Twitter Share on Facebook Share on Linkedin
 Biotronik's LivIQ leadless pacemaker offers a single-device solution designed to deliver atrioventricular (AV) synchrony through advanced electrical atrial far-field sensing.
The LivIQ leadless pacemaker offers a single-device solution designed to deliver AV synchrony through far-field sensing. 
READ MORE >

Tech breakthroughs, new policies help cardiologists perform more concomitant EP procedures

Devi Nair, MD, spoke to Cardiovascular Business about her own experience using concomitant LAA occlusion as an add-on to catheter ablation procedures.

READ MORE >
Devi Nair, MD, director of electrophysiology and research, St. Bernards Medical Center and Arrhythmia Research Group, explains how she uses concomitant left atrial appendage occlusion during EP procedures, and talks about new LAAO devices and ICE imaging.
Share on Twitter Share on Facebook Share on Linkedin

Tech breakthroughs, new policies help cardiologists perform more concomitant EP procedures

Share on Twitter Share on Facebook Share on Linkedin
Devi Nair, MD, director of electrophysiology and research, St. Bernards Medical Center and Arrhythmia Research Group, explains how she uses concomitant left atrial appendage occlusion during EP procedures, and talks about new LAAO devices and ICE imaging.
Devi Nair, MD, spoke to Cardiovascular Business about her own experience using concomitant LAA occlusion as an add-on to catheter ablation procedures.
READ MORE >

AI tool helps remote monitoring clinics explore patient data

The new AI-enabled resource works like a search engine and delivers answers in seconds.

READ MORE >
AI healthcare doctor surgery procedure artificial intelligence
Share on Twitter Share on Facebook Share on Linkedin

AI tool helps remote monitoring clinics explore patient data

Share on Twitter Share on Facebook Share on Linkedin
AI healthcare doctor surgery procedure artificial intelligence
The new AI-enabled resource works like a search engine and delivers answers in seconds.
READ MORE >

Conduction system pacing after TAVR linked to improved outcomes in new meta-analysis

Researchers explored data from nearly 800 patients, focusing on a wide variety of outcomes.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Conduction system pacing after TAVR linked to improved outcomes in new meta-analysis

Share on Twitter Share on Facebook Share on Linkedin
Researchers explored data from nearly 800 patients, focusing on a wide variety of outcomes.
READ MORE >

Inflammation may help explain how GLP-1 drugs prevent AFib

Kenneth Bilchick, MD, spoke to Cardiovascular Business about new data he presented at Heart Rhythm 2026. 

READ MORE >
Kenneth Bilchick, MD, MS, Director of Electrophysiology Research, and a professor of cardiovascular medicine at the University of Virginia, explains GLP-1 receptor agonists (GLP-RAs) may do more than drive weight loss—showing a significantly lower risk of atrial fibrillation.
Share on Twitter Share on Facebook Share on Linkedin

Inflammation may help explain how GLP-1 drugs prevent AFib

Share on Twitter Share on Facebook Share on Linkedin
Kenneth Bilchick, MD, MS, Director of Electrophysiology Research, and a professor of cardiovascular medicine at the University of Virginia, explains GLP-1 receptor agonists (GLP-RAs) may do more than drive weight loss—showing a significantly lower risk of atrial fibrillation.
Kenneth Bilchick, MD, spoke to Cardiovascular Business about new data he presented at Heart Rhythm 2026. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

New antiplatelet recommendations | Heart failure drug recalled | Imaging tech makes US debut | Conavi Medical's good news
Safety concerns lead to new recall | FDA approves surgical device | Parents in jail after obese son's death | A fraud warning
AI making an impact behind the scenes | New EARLY TAVR data | Americans keep poisoning themselves with semaglutide
Week in Review: TAVR vs. SAVR | FDA clears AI tech | Payment model confusion | Private equity & cardiology | Injuries after PCI
Heart surgery kits recalled | Sex-specific outcomes after TAVR & SAVR | A new risk calculator | FDA clears tricuspid valve
Thousands of heart surgery kits recalled | TAVR for AR linked to 'encouraging' data | Carotid IVL | Progress for new HCM drug
AI company founded by cardiologist makes big splash | Getting clinicians on the same page | Kidney injuries after PCI

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup